DHX9 and neoplasm: Consistent results were also observed in in vivo subcutaneous xenograft experiments, in which treatment with Cis plus Rha repressed tumor stemness, slowed tumor growth, and decreased tumor weight compared with treatment with Cis or Rha alone.